ALL PROPOSALS
MUST BE SUBMITTED THROUGH ISPOR'S ONLINE ABSTRACT SYSTEM
BY 22 MARCH 2012, 11:59 PM (PST).
GENERAL INFORMATION
- All research abstract submissions, workshop or issue panel proposals, or case studies must be in English.
- All research abstract, decision-maker case study abstract, workshop and issue panel proposal submissions and presentations must not promote any product or service.
- Expenses associated with the submission and presentation of an abstract are the responsibility of the presenter.
- Conference registration is required for all presenters.
- The presenters of research are required to disclose financial support. Abstract review will NOT be based on this information.
- The research abstracts, workshops or issue panel proposals, excluding title and author information, should be no longer than 300 words. Decision-maker Case Study abstracts should be no longer than 750 words.
- The use of tables and graphs in your research abstract submission, workshop or issue panel proposals, or case studies are not allowed.
- Generic names should be used for technologies (drugs, devices), not trade names.
- Research that has been published or presented at any national or international meeting prior to this Conference is discouraged.
- Research presented at a previous ISPOR meeting is not allowed.
- Multiple abstracts on the same study are discouraged.
RESEARCH SUBMISSION INFORMATION
- Research abstracts (except Conceptual Papers and Research on Methods abstracts) must be organized as follows: OBJECTIVES:
METHODS: RESULTS: CONCLUSIONS:
- Research on all diseases is considered. Study methods
include, but are not limited to, conjoint analysis, large
database analysis, quasi-experimental analysis, literature
or record review, modeling, naturalistic (observational)
studies, randomized clinical trials, surveys.
- Research on all health care interventions is considered
including drugs, behavioral modification, disease prevention,
gene therapy, medical device, screening, diagnostic
procedures, dietary, health education, radiation therapy,
and surgical procedures.
- Reviews or methods papers are also considered as
research abstracts.
- Accepted abstracts will be published AS SUBMITTED in VALUE IN HEALTH. Changes to abstracts will not be accepted after the Submission Deadline; therefore, they should be carefully written and edited prior to submission.
STEP 1: TITLE
When submitting your abstract, titles must be submitted in all CAPS.
STEP 2: RESEARCH TOPICS AND SUBTOPICS FOR RESEARCH SUBMISSIONS
When submitting your abstract, you must select a topic and subtopic that best describes your research. Topic subcategories are listed after each topic below to aid in your selection.
| |
• Clinical Outcomes Studies (COS) |
| |
□ Adverse Events (SE)
□ Co-morbidities (CMB)
□ Diagnosis (D)
□ Efficacy/Effectiveness/Comparative Effectiveness (EE)
□ Pharmacoepidemiology (PEP)
□ Prevalence/Incidence (PV)
□ Risk Factors/Confounding Factors (RF)
□ Safety (SA)
□ Survival (S)
|
| |
• Cost Studies (CS) |
| |
□ Budget Impact (BI)
□ Cost-Benefit Analysis (CB)
□ Cost-Consequence (CN)
□ Cost-Effectiveness Analysis (CE)
□ Cost-Efficiency Analysis (CEE)
□ Cost-Minimization Analysis (CM)
□ Cost-Utility Analysis (CU)
□ Cost of Illness (CoI)
□ Cost of Treatment (CoT)
□ Cost Comparison (CC)
□ Health Econometrics (E)
□ Productivity (PI)
□ Resource Use (RU)
□ Valuation (V)
|
| |
• Patient-Reported Outcomes & Patient Preference Studies |
| |
□ Adherence/Compliance/Persistence (AD)
□ Health States/Utilities (HS)
□ Instrument Development/Validation (IV)
□ Patient-Reported Outcomes (PRO)
□ Patient/Social Preference (PP)
□ Patient Satisfaction (PS)
□ Quality-of-Life (hrQoL)
□ Treatment Satisfaction (TS)
□ Willingness-to-Pay (WTP)
□ Work Performance (WP)
|
| |
• Health Care Use & Policy Studies (HP) |
| |
□ Consumer Role in Health Care (CRH)
□ Coverage with Evidence Development (CED)
□ Diagnosis Related Group (DRG)
□ Disease Management (DISM)
□ Drug or Devices & Health Policy (DHP)
□Drug Use (DU)
□ Equity, Access, Quality Improvement and Quality of Care (EAQ)
□ Formulary Development/Pharmacy Benefit (FD)
□ Health Care Expenditure/Resource Use (HE)
□ Health Care Information (HI)
□ Health Care Management (including Drug Management) (HM)
□ Health Care Reimbursement (HR)
□ Health Care Research (HCR)
□ Health Status/Population Health (PH)
□ Health Technology Assessment Programs (HTA)
□ Patient/Provider/Payer/Regulator/Researcher Education (PE)
□ Patient Registries or Post Marketing Studies (PR)
□ Prescribing Behavior (PB)
□ Quality of Care including Quality Improvement (QC)
□ Regulation of Health Care Sector (RHS)
□ Risk Sharing/Performance-Based Agreements (RS)
□ Treatment Patterns/Guidelines (TPG)
|
| |
• Research on Methods (RM) |
| |
□ Clinical Outcomes Methods (COS)
□ Cost Methods including CE/CB/CU, resource use, productivity, valuation and health econometrics (CS)
□ Databases & Data Management Methods (DM)
□ Modeling Methods (MS)
□ Quality of Life/Patient Reported Outcomes/ePRO/Utility/Preference Studies including Instrument Development & Validation (QOL)
□ Statistical Methods (SM)
□ Study Design (SD)
|
| |
• Conceptual Papers (CP) |
| |
□ Health Care Conceptual Papers (HCP)
□ Methods Conceptual Papers (MCP)
□ Other Conceptual Papers (OCP)
|
STEP 3: DISEASE/DISORDER FOR RESEARCH SUBMISSIONS
When submitting your abstract, you must select the DISEASE/ DISORDER that best describes your research. If no disease or multiple diseases apply to your abstract, select Multiple Diseases/No Specific Disease
| View Diseases |
- Allergy
- Arthritis-Osteoarthritis
- Arthritis-Other
- Arthritis-Rheumatoid Arthritis
- Asthma
- Auto-immune disorders
- Cancer
- Cardiovascular Disease-Hypercholesterolemia/Hyperlipidemia
- Cardiovascular Disease-ALL
- Cardiovascular Disease-Angina/Ischemia/Coronary Syndrome
- Cardiovascular Disease-Angioplasty
- Cardiovascular Disease-Arrhythmia
- Cardiovascular Disease-Atrial Fibrillation
- Cardiovascular Disease-Congestive Heart Failure/Heart Failure
- Cardiovascular Disease-Coronary Artery Disease
- Cardiovascular Disease-Hypertension
- Cardiovascular Disease-Left Ventricular Dysfunction (LVD)
- Cardiovascular Disease-Myocardial Infarction
- Cardiovascular Disease-Other
- Cardiovascular Disease-Peripheral Arterial Disease
- Cardiovascular Disease-Stents
- Cardiovascular Disease-Thrombosis including DVT
- Dental Disorders
- Diabetes
- Ear Diseases/Disorders
- Endocrine Disorders-Other (Pituitary Gland/Thyroid)
- Eye Diseases/Disorders
- Genetic Disorders
- GI Disorders (including Dyspepsia, GERD, Irritable Bowel, Liver, Ulcers)
- Health-Children
- Health-Elderly
- Health-Men
- Health-Women
- Hematological Disorders
- Infection (including Leg Ulcers & Bronchitis)
- Infection-HIV
- Infection-Influenza
- Infection-Vaccine
- Mental Health-Alcoholism/Drug Abuse
- Mental Health-Anxiety
- Mental Health-Attention Deficit Disorder
- Mental Health-Bi-Polar Disorder
- Mental Health-Dementia
- Mental Health-Depression
- Mental Health-Obsessive Compulsive Disorder
- Mental Health-Other
- Mental Health-Psychosis
- Mental Health-Schizophrenia
- Metabolic Disorders (not diabetes)
- Muscular-skeletal Disorders (including Carpal Tunnel Syndrome)
- Neurological Disorders-Alzheimer’s Disease
- Neurological Disorders-Cystic Fibrosis
- Neurological Disorders-Epilepsy
- Neurological Disorders-Migraine
- Neurological Disorders-Multiple Sclerosis
- Neurological Disorders-Other
- Neurological Disorders-Parkinson’s Disease
- Neurological Disorders-Restless Leg Syndrome
- Neurological Disorders-Sleep Disorders
- Obesity
- Osteoporosis (including Falls, Injuries, Bone Disorders)
- Pain
- Respiratory Disorders (including Chronic Obstructive Pulmonary Disease [COPD])
- Skin (including hair loss) Diseases/Disorders
- Smoking
- Stroke
- Urinary/Kidney (including Renal Disease, Irritable Bladder Syndrome)
- Multiple Diseases/No Specific Disease
|
STEP 4: HEALTH CARE TREATMENT FOR RESEARCH SUBMISSIONS
When submitting your abstract, you must select the HEALTH CARE TREATMENT that best describes your research.
| View Treatments |
- Drug
- Health Services
- Medical Device/Diagnostics
- Nutrition
- Personalized Medicine/Pharmocogenomics
- Surgery
- Traditional Medicine/Homeopathic Medicine
- Veterinary Medicine
- Other-Treatments
- ALL Treatments or NO Specific Treatment
|
CRITERIA FOR EVALUATION OF RESEARCH ABSTRACTS:
Quality of study criteria (for research study or research on methods abstracts):
**Note: For studies involving data collection or
analysis, the abstract will be REJECTED if RESULTS are
NOT included.**
- Research design is appropriate & transparent.
- Data sources are appropriate & transparent.
- Data analyses are appropriate & transparent.
- Results ARE INCLUDED and are transparent and
comprehensible.
- Conclusions are consistent with the results.
Quality of conceptual paper abstracts:
- Approach to concept is apparent.
- Sufficient background information is provided.
- Practical implications/recommendations are provided.
- Conclusions or recommendations are consistent with the goal of the abstract
QUALITY OF THE ABSTRACT PRESENTATION CRITERIA:
- Objectives/research questions are clearly stated and
objectives are addressed.
- Factual information is kept separate from interpretations or implications/unbiased presentation.
- Implications/results, as presented, are easy to understand.
- Presentation appears unbiased and is not promoting a product or service
Research Abstract Example
|
